Swiss National Bank’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.4M | Buy |
203,700
+9,400
| +5% | +$249K | ﹤0.01% | 1252 |
|
2025
Q1 | $4.69M | Sell |
194,300
-1,900
| -1% | -$45.9K | ﹤0.01% | 1299 |
|
2024
Q4 | $7.9M | Buy |
196,200
+2,400
| +1% | +$96.6K | 0.01% | 1060 |
|
2024
Q3 | $12.3M | Buy |
193,800
+200
| +0.1% | +$12.7K | 0.01% | 840 |
|
2024
Q2 | $10.3M | Buy |
193,600
+25,000
| +15% | +$1.33M | 0.01% | 898 |
|
2024
Q1 | $13.8M | Buy |
168,600
+1,000
| +0.6% | +$82K | 0.01% | 768 |
|
2023
Q4 | $3.12M | Sell |
167,600
-29,900
| -15% | -$556K | ﹤0.01% | 1590 |
|
2023
Q3 | $2.19M | Sell |
197,500
-8,500
| -4% | -$94.1K | ﹤0.01% | 1784 |
|
2023
Q2 | $3.34M | Buy |
206,000
+39,100
| +23% | +$634K | ﹤0.01% | 1563 |
|
2023
Q1 | $2.78M | Buy |
+166,900
| New | +$2.78M | ﹤0.01% | 1630 |
|
2022
Q2 | – | Sell |
-166,500
| Closed | -$500K | – | 2794 |
|
2022
Q1 | $500K | Buy |
166,500
+11,200
| +7% | +$33.6K | ﹤0.01% | 2606 |
|
2021
Q4 | $714K | Hold |
155,300
| – | – | ﹤0.01% | 2579 |
|
2021
Q3 | $975K | Buy |
155,300
+10,100
| +7% | +$63.4K | ﹤0.01% | 2448 |
|
2021
Q2 | $870K | Sell |
145,200
-4,800
| -3% | -$28.8K | ﹤0.01% | 2528 |
|
2021
Q1 | $949K | Buy |
150,000
+3,000
| +2% | +$19K | ﹤0.01% | 2360 |
|
2020
Q4 | $828K | Hold |
147,000
| – | – | ﹤0.01% | 2367 |
|
2020
Q3 | $856K | Hold |
147,000
| – | – | ﹤0.01% | 2168 |
|
2020
Q2 | $1.06M | Buy |
147,000
+22,600
| +18% | +$163K | ﹤0.01% | 2067 |
|
2020
Q1 | $582K | Hold |
124,400
| – | – | ﹤0.01% | 2116 |
|
2019
Q4 | $998K | Buy |
124,400
+4,800
| +4% | +$38.5K | ﹤0.01% | 2140 |
|
2019
Q3 | $823K | Hold |
119,600
| – | – | ﹤0.01% | 2155 |
|
2019
Q2 | $993K | Buy |
119,600
+2,400
| +2% | +$19.9K | ﹤0.01% | 2113 |
|
2019
Q1 | $1.17M | Buy |
117,200
+5,600
| +5% | +$55.7K | ﹤0.01% | 1988 |
|
2018
Q4 | $854K | Buy |
+111,600
| New | +$854K | ﹤0.01% | 2092 |
|